Pharmaceutical drug executives are facing tight deadlines and additional requirements for serialization methods due to new federal regulations. The regulations mandate full unit-level traceability for dispensers and require product identifiers on all packages by 2023, significantly impacting production timelines. Organizations not previously affected by state mandates must now implement comprehensive serialization across wider networks, resulting in increased operational challenges.